Polarean Imaging Plc - New System Installation

10 September 2019

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, announces that further to the announcement of 5 June 2019, the Company has delivered and installed its latest 9820 Xenon Polariser system at the Hospital for Sick Children (“SickKids”) in Toronto www.sickkids.ca.

SickKids is a major paediatric research and teaching hospital and already has an earlier model Polarean polariser (which was recently upgraded). This new unit will expand SickKids’ ongoing paediatric research programme using hyperpolarised gas imaging. Their order was enabled by a grant from the Canada Foundation for Innovation (“CFI”) www.innovation.ca/about. Following this installation, the total number of the Company’s polarisers that are either installed or on order is 24.

Giles Santyr, PhD, FCCPM, Senior Scientist, Translational Medicine at The Hospital for Sick Children (“SickKids”) said: “The purchase of this second polariser will significantly improve our capabilities to image children faster and with higher image quality, enabling several new paediatric lung MRI projects. We acknowledge the generous support of the Canada Foundation for Innovation and the Research Institute of the Hospital for Sick Children, for helping make this new equipment possible.”

Richard Hullihen, CEO of Polarean, said: “We have now delivered and installed our latest polariser, which is a significant set up in capabilities for the researchers at SickKids. We look forward to enabling their new discoveries in these critical projects.”

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

Enquiries: